References
- Hedlund P. O., Jacobsson H, Vaage S, Hahne B, Sandin T, Kontturi M, Nordle Ö, Esposti P, the SPCG-1 Study Group. Treatment of high-grade, high-stage prostate cancer with estramustine phosphate or diethylstilbestrol. Scand J Urol Nephrol 1997, (accepted for publication)
- Hörder M, Rasmussen F. Acid phosphatases and other tumor markers in the management of prostate cancer. Scand J Clin Invest 1985, Suppl 179: 45
- Iversen P, the Scandinavian Prostatic Cancer Group. Prostate cancer. Views on evaluation and treatment. Scand J Urol Nephrol 1991; 25(Suppl 139)
- Jörgensen T, Tveter K J, the members of the SPCG-2 Group. Jörgensen L H. Total Androgen Suppression: Experience from the Scandinavian Prostatic Cancer Group Study No. 2. Eur Urol 1993; 24: 466–470